Medicare Enrolled
Dr. Pramod Gaudel, M.D
Hematology & Oncology · Athens, GA
Practice pattern: Mixed Practice
— Diverse clinical practice across multiple procedure types
Low-engagement
Very High
DATA COVERAGE
Data in 4 of 4 federal sources
Measures public federal data availability — not provider quality
Informational, not a quality rating.
This page presents federal public records about Dr. Gaudel from CMS (NPPES, Open Payments, Medicare Provider Utilization, PECOS). It is not medical advice, an endorsement, or a judgment of clinical quality. Always consult the provider directly and a licensed clinician for medical decisions. Read methodology →
Are you Dr. Gaudel?
Request a correction or review of any data shown here. Provider portal →
What this data tells you about Dr. Gaudel
Dr. Pramod Gaudel is a hematology & oncology specialist in Athens, GA, with 10 years of NPI registration. Based on federal Medicare data, Dr. Gaudel performed 3,880 Medicare services across 681 unique beneficiaries.
Between the years covered by Open Payments, Dr. Gaudel received a total of $5,451 from 60 pharmaceutical and/or device companies across 243 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common in hematology & oncology. Most payments are for meals and travel — low-value interactions common across virtually all practicing physicians. Patients may wish to discuss these relationships with their provider.
The Data Coverage level for Dr. Gaudel is Very High — reflecting how much public federal data is available about this provider. Patients are encouraged to use this data as one of several factors when choosing a healthcare provider.
✓ 10 years in practice
▲ Top 22% volume in GA
$5,451 industry payments
Medicare Practice Summary
Medicare Utilization ↗3,880
Medicare services
Top 22% in GA for hematology & oncology
681
Unique beneficiaries
$8
Avg. Medicare payment
Medicare patients only (65+ / disabled) · How to read this →
~388 Medicare services per year of practice
Top procedures by volume
Ranked by number of services performed for Medicare patients. Avg. submitted charge is what the provider billed; avg. Medicare payment is what CMS paid.
| Procedure | Volume | Avg. paid | Avg. submitted |
|---|---|---|---|
| Contrast dye for imaging (iodine-based) A contrast agent containing 300-399 mg/ml of iodine used to enhance imaging studies. It is administered per milliliter to improve the visibility of internal structures. |
1,700 | $0 | $3 |
| Dexamethasone injection (steroid) An injection of dexamethasone sodium phosphate, a corticosteroid medication, administered in a dose of 1 milligram. |
574 | $0 | $0 |
| Anti-nausea injection (Aloxi/palonosetron) | 300 | $1 | $14 |
| Blood draw (venipuncture) Insertion of a needle into a vein to collect a blood sample. |
135 | $8 | $22 |
| Additional sequential IV infusion, 1 hour or less This code represents an additional intravenous infusion administered sequentially to a primary infusion. It covers the administration time of one hour or less. |
127 | $21 | $151 |
| Comprehensive metabolic blood panel A blood test that measures a group of chemicals, including glucose, electrolytes, and kidney and liver function markers. |
110 | $10 | $73 |
| Manual white blood cell count A laboratory test that involves examining a sample under a microscope to manually count the number of white blood cells present. |
104 | $4 | $27 |
| Office visit, established patient (30-39 min) A follow-up office visit for an existing patient lasting between 30 and 39 minutes. The visit involves medical evaluation and management of the patient's condition. |
104 | $81 | $256 |
| Complete blood count (CBC), automated An automated laboratory test that measures the levels of red blood cells, white blood cells, and platelets in the blood. |
103 | $6 | $43 |
| Intravenous injection of additional new drug or substance Administration of an additional new medication or substance directly into a vein. |
78 | $11 | $75 |
| Intravenous chemotherapy infusion, 1 hour or less Administration of chemotherapy medication directly into a vein. The procedure takes one hour or less to complete. |
61 | $96 | $515 |
| Complete blood count (CBC) with differential An automated laboratory test that measures the levels of red blood cells, white blood cells, and platelets in the blood, including a breakdown of the different types of white blood cells. |
47 | $8 | $42 |
| Immunoglobulin level test A blood test that measures the level of gammaglobulins, which are immune system proteins. |
45 | $9 | $82 |
| Lactate dehydrogenase (LDH) level test A blood test that measures the amount of lactate dehydrogenase, an enzyme found in many body tissues. It helps assess tissue damage or disease. |
45 | $6 | $37 |
| Diphenhydramine injection, up to 50 mg An injection of diphenhydramine hydrochloride, an antihistamine medication, administered in a dose of up to 50 milligrams. |
41 | $1 | $2 |
| Drug injection, under skin or into muscle A procedure involving the administration of a medication or substance via injection into the subcutaneous tissue or muscle. |
34 | $11 | $63 |
| Ferritin level test (iron stores) A blood test that measures the level of ferritin, a protein that stores iron in the body. |
31 | $13 | $127 |
| Iron level test | 31 | $6 | $55 |
| Iron binding capacity test A blood test that measures the amount of iron in the blood and the blood's ability to bind and transport iron. |
31 | $9 | $76 |
| Intravenous infusion of new drug or substance, 1 hour or less This procedure involves administering a new medication or substance directly into a vein through an existing access site. The infusion is completed within one hour or less. |
29 | $48 | $244 |
| Magnesium level test A blood test to measure the amount of magnesium in your body. This helps check for magnesium deficiency or excess. |
26 | $7 | $56 |
| Vitamin B-12 level test A blood test that measures the amount of vitamin B-12 in your body. |
21 | $15 | $115 |
| Office visit, established patient (20-29 min) An office visit for an existing patient lasting between 20 and 29 minutes. The visit involves medical evaluation and management of the patient's condition. |
20 | $55 | $163 |
| Normal saline infusion, 1000 cc Administration of 1000 cc of normal saline solution into a vein. This procedure involves the intravenous delivery of a sterile saltwater solution. |
19 | $2 | $11 |
| Office visit, established patient, complex (40-54 min) An office or outpatient visit for an existing patient lasting between 40 and 54 minutes. This level of service is determined by the total time spent on the date of the encounter. |
15 | $135 | $286 |
| Folic acid level test A blood test that measures the amount of folic acid in the serum. |
14 | $14 | $113 |
| Automated red blood cell count An automated laboratory test that measures the number of red blood cells in a blood sample. |
13 | $4 | $38 |
| Basic blood chemical test (calcium, ionized) A blood test that measures basic chemical levels, specifically including calcium and ionized calcium. |
11 | $13 | $48 |
| New patient office visit, complex (60-74 min) | 11 | $150 | $421 |
How to read this data: This reflects Medicare patients only (typically 65+). Payment amounts are what Medicare paid the provider, not your out-of-pocket cost. A higher procedure volume generally indicates more experience with that procedure.
6.1% high complexity
70.3% medium
23.6% routine
Industry Payment Transparency
Open Payments through 2024 ↗$5,451
Total received (2021-2024)
Avg $1,363/year across 4 years
Top 43% in GA for hematology & oncology
A higher payment rank reflects disclosed industry relationships (consulting, research, speaking) common among subspecialists — not wrongdoing.
60
Companies
243
Individual payments
All payments are legal and publicly reported · Not evidence of wrongdoing · How to interpret →
Payment profile
Industry payments classified by relationship type. Not all payments are equal — research and consulting reflect different relationships than speaking programs or meals.
Meals & Travel
Food, beverages, travel, and lodging — typically low-value
$5,429 (99.6%)
Speaking / Promotional
Speaker programs, honoraria, and industry-sponsored educational events
$22 (0.4%)
Payment trend by year
Annual totals from pharmaceutical and medical device companies.
2024
$4,175
2023
$507
2022
$749
2021
$20
Payments by company (2024)
Consulting
Speaking
Meals & Travel
Research
PFIZER INC.
$357
Merck Sharp & Dohme LLC
$274
Celgene Corporation
$266
Daiichi Sankyo Inc.
$248
AstraZeneca Pharmaceuticals LP
$235
ABBVIE INC.
$231
Takeda Pharmaceuticals U.S.A., Inc.
$208
Genentech USA, Inc.
$189
GlaxoSmithKline, LLC.
$154
JAZZ PHARMACEUTICALS INC.
$141
GENZYME CORPORATION
$139
SOBI, INC
$138
Janssen Biotech, Inc.
$108
Alexion Pharmaceuticals, Inc.
$97
Novartis Pharmaceuticals Corporation
$94
Eisai Inc.
$88
Regeneron Healthcare Solutions, Inc.
$83
Astellas Pharma US Inc
$75
Gilead Sciences, Inc.
$71
PUMA BIOTECHNOLOGY, INC.
$68
Stemline Therapeutics Inc.
$67
Rigel Pharmaceuticals, Inc.
$51
PharmaEssentia USA Corporation
$47
Deciphera Pharmaceuticals Inc.
$46
Karyopharm Therapeutics Inc.
$46
Lilly USA, LLC
$44
Exelixis Inc.
$42
Adaptive Biotechnologies Corporation
$41
BeiGene USA, Inc.
$40
Incyte Corporation
$37
ARRAY BIOPHARMA INC
$35
TerSera Therapeutics LLC
$32
Dendreon Pharmaceuticals LLC
$31
Boehringer Ingelheim Pharmaceuticals, Inc.
$30
Acrotech Biopharma Inc.
$26
Mirati Therapeutics, Inc.
$25
Geron Corporation
$24
Ipsen Biopharmaceuticals, Inc
$24
EMD Serono, Inc.
$22
Genmab U.S., Inc.
$22
Janssen Pharmaceuticals, Inc
$22
SERVIER PHARMACEUTICALS LLC
$21
Immunocore Limited
$21
Coherus Biosciences Inc.
$21
ADC Therapeutics America, Inc.
$21
Legend Biotech USA Inc.
$19
RECORDATI_RARE_DISEASES_INC.
$19
Myriad Genetic Laboratories, Inc.
$17
Azurity Pharmaceuticals, Inc.
$14
Top 3 companies account for 21.5% of 2024 payments
All-time payments by company (2021-2024) ›
Daiichi Sankyo Inc.
$428
PFIZER INC.
$393
Merck Sharp & Dohme LLC
$327
ABBVIE INC.
$310
AstraZeneca Pharmaceuticals LP
$307
Celgene Corporation
$296
Genentech USA, Inc.
$227
Takeda Pharmaceuticals U.S.A., Inc.
$225
GENZYME CORPORATION
$206
GlaxoSmithKline, LLC.
$168
Astellas Pharma US Inc
$160
Novartis Pharmaceuticals Corporation
$144
JAZZ PHARMACEUTICALS INC.
$141
SOBI, INC
$138
Eisai Inc.
$122
Janssen Biotech, Inc.
$118
Alexion Pharmaceuticals, Inc.
$114
Incyte Corporation
$94
Stemline Therapeutics Inc.
$90
Karyopharm Therapeutics Inc.
$88
Gilead Sciences, Inc.
$85
Regeneron Healthcare Solutions, Inc.
$83
Adaptive Biotechnologies Corporation
$68
PUMA BIOTECHNOLOGY, INC.
$68
Rigel Pharmaceuticals, Inc.
$67
Lilly USA, LLC
$61
PharmaEssentia USA Corporation
$47
Deciphera Pharmaceuticals Inc.
$46
Exelixis Inc.
$42
BeiGene USA, Inc.
$40
Blueprint Medicines Corporation
$40
Genmab U.S., Inc.
$39
Amgen Inc.
$37
ADC Therapeutics America, Inc.
$36
Seagen Inc.
$36
SERVIER PHARMACEUTICALS LLC
$35
ARRAY BIOPHARMA INC
$35
TerSera Therapeutics LLC
$32
Apellis Pharmaceuticals, Inc.
$31
Dendreon Pharmaceuticals LLC
$31
Boehringer Ingelheim Pharmaceuticals, Inc.
$30
Acrotech Biopharma Inc.
$26
Mirati Therapeutics, Inc.
$25
Geron Corporation
$24
Ipsen Biopharmaceuticals, Inc
$24
EMD Serono, Inc.
$22
Janssen Pharmaceuticals, Inc
$22
Immunocore Limited
$21
Coherus Biosciences Inc.
$21
CTI BioPharma Corp.
$21
Legend Biotech USA Inc.
$19
RECORDATI_RARE_DISEASES_INC.
$19
Servier Pharmaceuticals LLC
$18
Myriad Genetic Laboratories, Inc.
$17
Pharmacyclics LLC, an AbbVie Company
$16
AVEO Pharmaceuticals, Inc.
$14
Azurity Pharmaceuticals, Inc.
$14
Octapharma USA, Inc.
$14
Mylan Institutional Inc.
$13
TOLMAR Pharmaceuticals, Inc.
$12
Top 3 companies account for 21.1% of all-time payments
Associated products mentioned in payments ›
ALUNBRIG · AYVAKIT · Alecensa · BELEODAQ · BESREMI · BOSULIF · BRAFTOVI · BRUKINSA · CABLIVI · CABOMETYX · CALQUENCE · CYRAMZA · Columvi · DARZALEX · DOPTELET · ELIGARD · ELITEK · ELREXFIO · ELZONRIS · ENHERTU · EPKINLY · Empaveli · Enhertu · Epkinly · FOTIVDA · FRUZAQLA · GAZYVA · IBRANCE · ICLUSIG · IMBRUVICA · IMFINZI · INJECTAFER · INLYTA · Itovebi · JAKAFI · JEMPERLI · KEYTRUDA · KIMMTRAK · KISQALI · KRAZATI · LIBTAYO · LORBRENA · LUMAKRAS · LUTATHERA · LYNPARZA · Lenvima · MEKINIST · MYRISK · NINLARO · Nplate · OCTAGAM IMMUNE GLOBULIN (HUMAN) · OJJAARA · OXBRYTA · Ogivri · Onivyde · Orserdu · PADCEV · PEMAZYRE · PROVENGE · Padcev · Perjeta · Phesgo · Pomalyst · QINLOCK · REBLOZYL · RYBREVANT · RYTELO · Rezlidhia · SARCLISA · SYLVANT · SYNAGIS · TAGRISSO · TALVEY · TEVIMBRA · TIBSOVO · TUKYSA · Tavalisse · Tibsovo · Tivdak · Trodelvy · ULTOMIRIS · Udenyca · VENCLEXTA · VERZENIO · VIVIMUSTA · VONJO · Venclexta · Vonjo · XPOVIO · XTANDI · Xtandi · ZEJULA · ZEPZELCA · Zoladex · clonoSEQ
Should you be concerned? Payments from pharmaceutical and device companies are legal and common — 57% of U.S. physicians receive at least one. They often reflect legitimate consulting, research, or education. What matters is whether a recommended drug or device appears in your doctor's payment records. If so, consider asking your doctor about it. How to interpret this data →
Most payments (100%) are for meals and travel — low-value interactions that are common across virtually all practicing physicians.
Geographic Context
Hematology & oncology specialists within 10 mi
10
Per 100K population
12.4
County median income
$85,012
Nearest hospital
ST MARY'S HOSPITAL
5.4 mi
5.4 mi
Data Sources
| Provider Registry | ✓ NPPES | Weekly updates |
| Medicare Enrollment | ✓ PECOS | Monthly updates |
| Practice Data | ✓ Medicare Util. | Annual (CY lag) |
| Industry Payments | ✓ Open Payments | CY 2024 |
| Disciplinary History | — Not public | N/A |
This provider has data in 4 of 4 available federal datasets, with a Data Coverage level of Very High. This reflects how much public data is available about a provider. How we calculate this →
Summary
Dr. Gaudel is a mixed practice specialist, with above-average Medicare volume (top 22% in GA), with low-engagement industry engagement.
This summary is auto-generated from federal data, describing data availability and patterns. Read our methodology →
Frequently Asked Questions
Is Dr. Gaudel experienced with contrast dye for imaging (iodine-based)?
Based on Medicare claims data, Dr. Gaudel performed 1,700 contrast dye for imaging (iodine-based) services. Research suggests that higher procedure volume is often associated with better outcomes, particularly for complex procedures. Note that Medicare data only captures patients aged 65 and older, so the total practice volume across all patients is likely higher.
Does Dr. Gaudel receive payments from pharmaceutical companies?
Yes. Dr. Gaudel received a total of $5,451 from 60 companies across 243 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common among physicians — 57% of all U.S. physicians receive at least one industry payment. Patients may wish to ask their doctor about these relationships, especially if a recommended drug or device appears in the payment records.
How do Dr. Gaudel's costs compare to other hematology & oncology specialists in Athens?
Dr. Gaudel's average Medicare payment per service is $8. Note that these figures represent what Medicare pays, not your out-of-pocket cost, which depends on your specific insurance plan and deductible. Procedure-level data above shows both what was submitted and what Medicare paid for each service type.
What does Data Coverage mean?
Data Coverage (currently Very High for Dr. Gaudel) measures how much public federal data is available about a provider. It is not a quality rating. A "Very High" or "High" level means the provider has data across multiple federal sources (NPPES, PECOS, Medicare Utilization, Open Payments), indicating a long track record of practice, Medicare participation, and industry disclosure. A "Low" or "Moderate" level may simply mean the provider is newer, does not see Medicare patients, or has not received any industry payments — none of which are inherently negative. Read our full methodology →
Is this data up to date?
Each data source has its own update cycle. Provider registry data (NPPES) is updated weekly. Medicare enrollment (PECOS) is updated monthly. Medicare practice data has a ~2 year lag — the most recent available is typically 2 years prior. Industry payment data (Open Payments) is published annually, usually in June, covering the prior calendar year. We display the data date prominently on each section so you always know how current it is. See our data freshness policy →
Explore related providers
Same specialty & city
Hematology & Oncology Specialists in Athens
Browse hematology & oncology specialists in Athens ranked by procedure volume and transparency data.
Highest volume
Top Hematology & Oncology Specialists in GA
Hematology & oncology specialists ranked by total Medicare services performed statewide.
Industry payments
Pharma Payments to Hematology & Oncology Specialists in GA
Which GA hematology & oncology specialists receive the most from drug and device companies.
By company
Daiichi Sankyo Inc. Payments to Doctors
See all physicians who received payments from Daiichi Sankyo Inc.
By company
PFIZER INC. Payments to Doctors
See all physicians who received payments from PFIZER INC.
By company
Merck Sharp & Dohme LLC Payments to Doctors
See all physicians who received payments from Merck Sharp & Dohme LLC.
About this page
All data on this page is sourced verbatim from public federal records published by the U.S. Centers for Medicare & Medicaid Services (CMS): NPPES ↗, Open Payments ↗, Medicare Provider Utilization ↗, and PECOS. Publication is mandated by the Physician Payments Sunshine Act (§6002 ACA, 42 U.S.C. §1320a-7h) and the Freedom of Information Act.
This page is not medical advice, an endorsement, a recommendation, or a quality rating. Data Coverage reflects data completeness — how much federal information exists for this provider — not clinical performance, patient outcomes, or quality of care. Always verify information directly with the provider and consult a licensed clinician before making medical decisions.
Provider corrections: Provider portal · Privacy questions: Privacy Policy · Terms: Terms of Use · Methodology: Methodology